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background: The prevalence of chromosomal abnormalities is assumed to be higher in infertile men and inversely correlated with
sperm concentration. Although guidelines advise karyotyping infertile men, karyotyping is costly, therefore it would be of beneﬁt to identify
men with the highest risk of chromosomal abnormalities, possibly by using parameters other than sperm concentration. The aim of this study
was to evaluate several clinical parameters in azoospermic and non-azoospermic men, in order to assess the prevalence of chromosomal
abnormalities in different subgroups of infertile men.
methods: In a retrospective cohort of 1223 azoospermic men and men eligible for ICSI treatment, we studied sperm parameters,
hormone levels and medical history for an association with chromosomal abnormalities.
results: The prevalence of chromosomal abnormalities in the cohort was 3.1%. No association was found between chromosomal
abnormalities and sperm volume, concentration, progressive motility or total motile sperm count. Azoospermia was signiﬁcantly associated
with the presence of a chromosomal abnormality [15.2%, odds ratio (OR) 7.70, P, 0.001]. High gonadotrophin levels were also associated
with an increased prevalence of chromosomal abnormalities (OR 2.96, P ¼ 0.013). Azoospermic men with a positive andrologic history had a
lower prevalence of chromosomal abnormalities than azoospermic men with an uneventful history (OR 0.28, P ¼ 0.047). In non-azoosper-
mic men, we found that none of the studied variables were associated with the prevalence of chromosomal abnormalities.
conclusions: We show that the highest prevalence of chromosomal abnormalities is found in hypergonadotrophic azoospermic men
with an uneventful andrologic history.
Key words: chromosomal abnormalities / male infertility / azoospermia / ICSI
Introduction
In men with poor sperm quality, the prevalence of chromosomal
abnormalities is assumed to be higher than in the general population
(ﬁrst reported by Chandley et al., 1975). Some chromosomal abnor-
malities, such as Klinefelter’s syndrome and Robertsonian transloca-
tions, are associated with infertility. Paternal chromosomal
abnormalities may increase the risk of recurrent miscarriages or a
child with congenital anomalies. As a consequence, the introduction
of ICSI as a means for men with poor sperm quality to produce off-
spring has caused concerns of increasing transmission of the
chromosomal abnormality to the progeny. Guidelines state that
screening for chromosomal abnormalities is a prerequisite before
ICSI treatment in the case of (severe) male infertility (NVOG, 1999;
Crosignani and Rubin, 2000; Foresta et al., 2002; NICE, 2004; AUA
and ASRM, 2006).
The reported prevalence of chromosomal abnormalities in infertile
men ranges from 3 to 19% (summarized by Martin, 2008), depending
on the population studied. In some studies, all male partners of infer-
tile couples were karyotyped, while other studies only did so for men
with extremely poor sperm quality. Because karyotyping is costly and
time-consuming, it would be of beneﬁt to identify those infertile men
†This study was partly presented as a poster at the ESHRE Annual meeting, Stockholm, 2011.
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who have the highest risk of carrying a chromosomal abnormality.
So far, few studies have taken into account sperm parameters and
patient factors of infertile men as possible risk factors for chromosom-
al abnormalities.
Some studies on sperm parameters have indicated that sperm con-
centration shows the best correlation with the presence of chromo-
somal abnormalities (Chandley et al., 1975; Chandley, 1979; De
Braekeleer and Dao, 1991; Bourrouillou et al., 1992; Van Assche
et al., 1996; Gekas et al., 2001; Clementini et al., 2005). These
studies report that with decreasing sperm concentration, the preva-
lence of chromosomal abnormalities increases, with most aberrations
found in azoospermic men (reviewed in Dul et al., 2010). However,
other studies could not conﬁrm this linear correlation in subgroups
of infertile men (van der Ven et al., 1997; Yoshida et al., 1997; Ricca-
boni et al., 2008; Dul et al., 2010). These conﬂicting results seem to be
caused by differences in the study populations (e.g. whether the
couples or the men were infertile) and in categorization of sperm
concentrations.
Sperm motility and morphology have also been studied in relation
to chromosomal abnormalities. In several studies, no difference in
these sperm parameters was found between men with normal and
abnormal karyotypes (Marmor et al., 1980; Matsuda et al., 1991;
Yoshida et al., 1997; Gekas et al., 2001). Some studies did ﬁnd a sig-
niﬁcant difference, but only in oligozoospermic men (Chandley et al.,
1975; Van Assche et al., 1996). Yoshida et al. (1997) found a signiﬁ-
cantly higher incidence of chromosomal abnormalities in men with a
low total motile sperm count (TMSC). The results of the studies on
sperm motility and morphology are therefore inconsistent and
sperm concentration is a confounder that has not been taken into
account in all studies.
Few studies on chromosomal abnormalities in infertile men have
focused on patient characteristics. No studies have been performed
on whether a positive family history for infertile (male) relatives, rela-
tives with recurrent miscarriages or children with multiple congenital
anomalies or mental retardation is a good predictor for chromosomal
abnormalities in infertile men. An increased prevalence of chromo-
somal abnormalities has been reported in men with testicular
atrophy, high levels of FSH or high levels of LH (Yoshida et al.,
1997). Other studies excluded men with these characteristics, or
found no differences in gonadotrophin levels between men with or
without chromosomal abnormalities (Haidl et al., 2000).
Most studies on the prevalence of chromosomal abnormalities have
focused on men with ‘unexplained’ infertility, excluding men with a
history of cryptorchidism, varicocele, radiotherapy, chemotherapy or
previous surgery. These characteristics from a man’s medical history
might be causally related to infertility, but it is also possible that infer-
tility and the characteristic have a common genetic origin. In the tes-
ticular dysgenesis syndrome an association has been suggested
between cryptorchidism, poor sperm quality and genetic abnormal-
ities (Akre and Richiardi, 2009). It has not been established whether
there is an independent correlation between these patient character-
istics and chromosomal abnormalities.
So far, sperm concentration is the most frequently studied param-
eter in relation to the prevalence of chromosomal abnormalities in
infertile men, and there have been no systematic studies on correla-
tions with other sperm parameters, hormone levels and patient char-
acteristics. In a previous study, we found a signiﬁcant difference in the
prevalence of chromosomal abnormalities between azoospermic and
non-azoospermic men, and in non-azoospermic men sperm
concentration was not correlated with chromosomal abnormalities
(Dul et al., 2010). The aim of the present study is to evaluate addition-
al sperm parameters and patient characteristics in azoospermic and
non-azoospermic men, in order to assess the prevalence of chromo-
somal abnormalities in different subgroups of infertile men.
Materials and Methods
We performed a retrospective cohort study in unselected male partners
of consecutive couples applying for ICSI and azoospermic men attending
our fertility clinic between November 1994 and October 2007. Couples
were eligible for ICSI in the case of severe male factor infertility (deﬁned
by TMSC , 4 million in repeated semen analyses, or when the yield of
a sperm preparation procedure with density-gradient centrifugation fol-
lowed by swim-up was ,0.5 million motile spermatozoa), or in the
case of total fertilization failure in a previous IVF procedure. These men
were karyotyped in accordance with the prevailing guideline of the
Dutch Society of Obstetrics and Gynaecology (NVOG, 1999). Before
intake, all men received a comprehensive questionnaire on duration of
infertility, previous pregnancies and their outcomes, andrologic history
and family history regarding infertility, recurrent miscarriages and children
with congenital abnormalities or mental retardation.
Men whose results of the chromosomal analysis and at least one sperm
analysis were available were included in the study. Data were collected by
chart review. In the Netherlands, no ethical board approval is required for
retrospective chart review and collection of anonymized data. Couples
attending our fertility clinic are informed at intake about the possible
use of their anonymized data for research purposes, and a ‘no objection
procedure’ is followed. Only patients who had not objected were included
in the present study.
Chromosomal analysis
Chromosomal analysis was performed on cultured peripheral lympho-
cytes. Five Giemsa-Trypsin-Giemsa-banded metaphase spreads with a
minimal banding resolution of 550 were analysed per patient. In the
case of numerical mosaics, 100 metaphases were examined by conven-
tional microscopic screening or ﬂuorescence in situ hybridization (FISH).
If structural chromosomal aberrations were present, the evaluation was
extended to additional molecular cytogenetic analysis by FISH or array
comparative genome hybridization, whenever appropriate. Chromosomal
heteromorphisms, as deﬁned in the 2009 International System for Human
Cytogenetic Nomenclature, were not considered as chromosomal abnor-
malities (Shaffer et al., 2009).
Sperm analysis
Sperm analyses were carried out according to the WHO criteria (WHO,
1999). Semen samples were analysed within 1 h following ejaculation
by using a computer-aided semen analyzer (Stro¨mberg Mika-cell motility
analyzer; Medical Technologies Montreux SA, Montreux, Switzerland)
(Togni et al., 1995). If the sperm concentration was ,3 million/ml,
standard microscopic investigation was performed. Semen volume,
sperm concentration and progressive motility (a + b quality), and TMSC
were recorded. Sperm samples directly collected in a medium were
excluded, as well as sperm analyses culminating in preparation procedures
for fertility treatments. All consecutive sperm analyses up to a maximum of
six were included in the study. Only data from the ﬁrst sperm analysis
were used for the statistical analyses.
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Serum FSH and LH levels were measured by ﬂuoroimmunometric deter-
mination on the AutoDelﬁa (Wallac/Perkin Elmer, Turku, Finland). Serum
total testosterone was measured by in-house radio-immunoassay, using
(1,2,6,73H)-testosterone as tracer (Amersham Biosciences, Buckingham-
shire, UK) (Pratt et al., 1975). Cut-off levels were chosen based on refer-
ence values in our laboratory, as well as on cut-off levels mentioned in
studies on hormone levels and Y chromosome microdeletions (Pieri
et al., 2002; Kunej et al., 2003; Vutyavanich et al., 2007; Wang et al., 2010).
Statistical analysis
Statistical analysis was carried out using the Statistical Package for the
Social Sciences version 18.0 for Windows (SPSS Inc., Chicago, IL, USA).
Data were described in absolute counts and proportions. Associations
were assessed by univariate binary logistic regression. Subsequently, a
multivariate binary logistic regression analysis was performed with
forward stepwise conditional inclusion of variables. At each step, the vari-
able with the next-lowest P-value was included. The maximum P-value for
inclusion was 0.4. Odds ratios (ORs), 95% conﬁdence interval (CI) and
P-values are presented. In the case of categorical variables, the OR repre-
sents the change in risk of carrying a chromosomal abnormality compared
with the reference category, as indicated in the results. For dichotomous
(yes/no) variables, the reference category was ‘no’. Results were consid-
ered statistically signiﬁcant when P, 0.05.
Results
The results of the chromosomal analysis and of at least one in-house
sperm analysis were available for 1223 men with azoospermia or
applying for ICSI. The median male age was 34.6 years (range
22.0–63.6) and the couples had a median duration of infertility of
2.9 years (range 0–17.6) at intake in our centre. A primary infertility
was present in 85.5% of the couples. In two couples (0.16%), it was
unknown whether they had had a previous pregnancy.
A chromosomal abnormality was found in 38 men (3.1%). These
abnormalities consisted of 19 gonosomal aberrations: ﬁve 47,XXY,
two 47,XXY/46,XY mosaics, three 47,XYY, one 47,XYY/46,XY
mosaic, three 45,X/46,XY mosaics, one 46,XX and four complex
aberrations of the X or Y chromosome. There were 19 autosomal
aberrations: ﬁve Robertsonian translocations, six reciprocal transloca-
tions and seven inversions and one individual had a Robertsonian
translocation as well as an inversion.
For all 1223 men, at least one sperm analysis was recorded. In 956
men (78.2%) at least two and in 558 men (45.6%) three or more
sperm analyses were available. The outcome of the binary logistic ana-
lyses of the parameters of the ﬁrst sperm analysis is shown in Table I.
Median sperm volume was 3.8 ml (range 0.1–15.1), median sperm
concentration was 5.0 million/ml (0–185), median progressive motil-
ity was 18% (0–100) and median TMSC was 2.184 million (0–466.2).
Of the sperm parameters studied, only sperm motility had a statistic-
ally signiﬁcant association with the risk of carrying a chromosomal
abnormality (OR 1.02). Sperm concentration and TMSC as continuous
variables showed no association with chromosomal abnormalities.
Only azoospermia was signiﬁcantly associated with the risk of carrying
a chromosomal abnormality (OR 7.70). As shown previously, the
prevalence of chromosomal abnormalities in non-azoospermic men
did not differ signiﬁcantly between the different categories of sperm
concentration (Dul et al., 2010). In 10/12 azoospermic men with an
aberrant karyotype, a gonosomal abnormality was found (83.3%),
while autosomal aberrations predominated in the non-azoospermic
men with an abnormal karyotype (17/26; 65.4%).
Table I also gives the results of the univariate regression analysis of
the patient characteristics. Hormone levels were not determined in all
patients. FSH was determined in 86.1% of azoospermic men and in
40.6% of non-azoospermic men. The combination of FSH and LH
was determined in 65.8% of azoospermic men and in 22.6% of non-
azoospermic men. Of the total cohort of 1223 men, a result for
serum gonadotrophins was available in 534 men (43.7%). Total testos-
terone was determined in 81.0% of men with azoospermia and 33.9%
of non-azoospermic men. Analysis of these data showed that men
with FSH. 10 IU/l or LH. 12 IU/l had an increased risk of a
chromosomal abnormality compared with men with normal gonado-
trophin levels (OR 2.94 and 9.42, respectively).
Compared with men whose partners had no previous pregnancy,
men who had achieved conception before, irrespective of its
outcome, had a lower risk of a chromosomal abnormality (OR
0.21). Total fertilization failure (TFF) in previous IVF treatment did
not show an association with chromosomal abnormalities. A history
of cryptorchidism or genital surgery did not inﬂuence the risk for
chromosomal abnormalities, nor did a positive family history for infer-
tility, recurrent miscarriage or children with congenital anomalies.
However, not all questionnaires were ﬁlled in completely and there
were data missing on several aspects of the medical history in our
cohort.
There was a signiﬁcant difference in the frequency of chromosomal
abnormalities between azoospermic and non-azoospermic men, and
therefore a univariate regression analysis for the various variables
was performed in both groups. Table II gives the results for the 79
azoospermic men in our cohort, and shows a positive association
between FSH and LH concentrations and chromosomal abnormalities.
LH . 12 IU/l signiﬁcantly increased the chance of ﬁnding a chromo-
somal abnormality (OR 6.83), but the increased risk in men with
FSH . 10 IU/l was not statistically signiﬁcant (OR 4.05). Azoospermic
men with a positive andrologic history (e.g. genital infection, chemo-
therapy, radiotherapy, vasectomy, testicular torsion, varicocele and
cryptorchidism) had a lower prevalence of chromosomal abnormal-
ities (OR 0.28) compared with men with an uneventful history.
Table III gives the results for the 1144 non-azoospermic men in our
cohort. No association was found between chromosomal abnormal-
ities and serum hormone levels, previous pregnancy, family history
or cryptorchidism. In this subgroup of men, no statistically signiﬁcant
association was found between chromosomal abnormalities and a
positive andrologic history.
Discussion
We found that the prevalence of chromosomal abnormalities was not
associated with any sperm parameter besides azoospermia, whereas
high gonadotrophin levels and a negative andrologic history were asso-
ciated with an abnormal karyotype.
Our study is based on data from a large cohort of infertile men who
were either azoospermic or eligible for ICSI, representing an unse-
lected population of males visiting a tertiary referral centre. The preva-
lence of chromosomal abnormalities found in our cohort was 3.1% (CI
2.1–4.1), which is in the lowest range of the 3–19% mentioned in
38 Dul et al.
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published studies (summarized by Dul et al., 2010). This may be
explained by the wide range in sperm quality in our cohort, as we
included azoospermic males as well as men with normozoospermia
who had TFF in a previous IVF treatment. This allowed us to
compare groups of men with different sperm qualities in relation to
chromosomal abnormalities.
The chromosomal abnormalities we found are comparable with
those reported in other studies in infertile men: gonosomal aberra-
tions are most frequently detected in men with azoospermia, while
autosomal abnormalities, e.g. translocations are the most frequently
reported aberrations in non-azoospermic men (Dohle et al., 2007;
O’Flynn O’Brien et al., 2010). The association of gonosomal aberra-
tions, in particular Klinefelter’s syndrome, and primary testicular
failure is well known (Forti et al., 2010). Balanced structural chromo-
some aberrations seldom result in azoospermia; they usually present
with a phenotype varying from severe oligozoospermia to
normozoospermia.
We performed our statistical analyses on the basis of the ﬁrst sperm
analysis recorded in our centre. There is a large within-subject variabil-
ity in consecutive sperm analyses (Keel, 2006; Francavilla et al., 2007;
Leushuis et al., 2010) and therefore, most guidelines on male infertility
recommend performing at least two, or even three, sperm analyses
(WHO, 1999; NICE, 2004; NVOG, 2004; AUA and ASRM, 2006;
Dohle et al., 2007). In our cohort of 1223 men, 12 men (1.3%)
switched from azoospermia to non-azoospermia or vice versa in one
of their subsequent sperm analyses. Because this did not inﬂuence
the prevalence of chromosomal abnormalities in the subgroups, and
the number of cases in our cohort would have decreased substantially
if we had included only men with two or more sperm analyses, we
decided to include only the results of the ﬁrst sperm analysis.
Azoospermia was signiﬁcantly associated with chromosomal abnor-
malities, but we saw no correlation between sperm concentration or
TMSC and chromosomal abnormalities in the non-azoospermic men.
Sperm motility did show a positive association with chromosomal
abnormalities. However, after analyzing the sperm concentration
categories separately, it appeared that this association only existed
in the severe oligozoospermia group (0–1 million/ml). It is therefore
likely that the association found is explained by the measurement
error of sperm motility in samples with very low concentrations
(WHO, 2010).
In our retrospective study, hormone levels had been determined in
fewer than half the cases. We found that FSH . 10 IU/l and LH .
12 IU/l were associated with chromosomal aberrations. Primary tes-
ticular failure is associated with high levels of gonadotrophins, and
.............................................
.............................................................................................................................................................................................
Table I Sperm parameters and patient characteristics in a cohort of 1223 men with azoospermia or applying for ICSI in
relation to chromosomal abnormalities.
Characteristic n Abnormal karyotype (38) Normal karyotype (1185) Univariate analysis
OR 95% CI P-value
Sperm volume per ml 1223 3.6 (0.2–13.9) 3.7 (0.1–15.1) 1.04 0.885–1.21 0.660
Sperm concentration per million/ml 1223 0.209 (0–40.0) 5.000 (0–185) 0.975 0.942–1.01 0.148
Azoospermia 79 15.2% 84.8% 7.70 3.72–15.9 ,0.001
Non-azoospermia 1144 2.3% 97.7% 1.0
Sperm motility per % 1144 26.0 (0–100) 18.0 (0–100) 1.020 1.003–1.018 0.024
TMSC per million 1223 0.1755 (0–38.5) 2.2000 (0–466.2) 0.984 0.952–1.02 0.345
Previous pregnancy by male partner 1214 5.3% 20.6% 0.214 0.051–0.827 0.035
Previous miscarriage(s) 244 50.0% 34.3% 1.92 0.118–31.0 0.647
ICSI because of TFF 1223 10.5% 15.3% 0.653 0.229–1.86 0.425
FSH per IU/l 532 19.0 (3.33–48.4) 7.00 (0.19–49.8) 1.07 1.04–1.11 ,0.001
FSH. 10 IU/l 532 60.9% 34.6% 2.94 1.25–7.27 0.014
LH per IU/l 262 6.57 (1–25.3) 3.90 (0.09–25.1) 1.20 1.09–1.33 ,0.001
LH. 12 IU/l 262 17.6% 2.4% 9.42 2.12–42.0 0.003
Increased gonadotrophinsa 534 60.9% 34.4% 2.96 1.26–6.98 0.013
Testosterone per nmol/l 452 15.50 (3.3–25) 16.55 (3.45–51) 0.947 0.880–1.02 0.148
Positive andrologic historyb 1191 36.8% 50.6% 0.570 0.292–1.11 0.100
Positive family historyc 1117 22.2% 18.6% 1.25 0.562–2.79 0.584
History of cryptorchidism 1190 23.7% 20.5% 1.21 0.563–2.58 0.632
Data are median (range) or prevalence.
n Number of cases of which data were available for analysis.
TMSC, total motile sperm count; FSH, follicle-stimulating hormone; LH, luteinizing hormone; TFF, total fertilization failure in previous IVF.
aIncreased gonadotrophins: FSH . 10 IU/l and/or LH . 12 IU/l.
bPositive andrologic history: cryptorchidism (245), genital infection (94), vasectomy (33), orchidectomy (49), radiotherapy (9), chemotherapy (18), testicular biopsy (31), hypospadia
or midline defect (8), varicocele (122), spermatocele (5), surgery for hydrocele (8), surgery of urethra or ejaculatory duct (9), surgery for inguinal hernia (121), accidental testicular
injury (29), testicular torsion (23), congenital anomaly of urogenital tract (13), exposition to diethylstilbestrol in utero (4). Note: several events may have occurred in one case.
cPositive family history: (male) relatives with infertility (144), recurrent miscarriages (49), children with congenital anomalies or mental retardation (34).
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Table II Sperm parameters and patient characteristics in a subgroup of 79 men with azoospermia in relation to
chromosomal abnormalities.
Characteristic n Abnormal karyotype (12) Normal karyotype (67) Univariate analysis
OR 95% CI P-value
Sperm volume per ml 79 4.1 (0.2–9.6) 3.2 (0.4–11) 1.25 0.969–1.61 0.085
Previous pregnancy by male partner 79 0 7.5% 0 0.999
FSH per IU/l 68 23.30 (4.6–48.4) 14.19 (0.29–49.8) 1.050 1.004–1.099 0.034
FSH. 10 IU/l 68 81.8% 52.6% 4.05 0.803–20.4 0.090
LH per IU/l 53 9.88 (2.5–25.3) 4.14 (0.1–21.3) 1.20 1.04–1.38 0.014
LH. 12 IU/l 53 33.3% 6.8% 6.83 1.11–42.0 0.038
Increased gonadotrophinsa 69 81.8% 51.7% 4.20 0.834–21.1 0.082
Testosterone per nmol/l 64 15 (3.30–25) 16 (3.45–27) 0.95 0.84–1.1 0.35
Positive andrologic historyb 77 50.0% 78.5% 0.275 0.077–0.984 0.047
Positive family historyc 71 27.3% 25.0% 1.13 0.264–7.80 0.873
History of cryptorchidism 77 41.7% 26.2% 2.02 0.564–7.21 0.280
Data are median (range) or prevalence.
n, Number of cases of which data were available for analysis.
FSH, follicle-stimulating hormone; LH, luteinizing hormone.
aIncreased gonadotrophins: FSH . 10 IU/l and/or LH . 12 IU/l.
bPositive andrologic history: cryptorchidism (22), genital infection (5), vasectomy (3), orchidectomy (5), radiotherapy (1), chemotherapy (2), testicular biopsy (25), hypospadia or
midline defect (2), varicocele (5), surgery for hydrocele (2), surgery for inguinal hernia (5), accidental testicular injury (1), testicular torsion (1), congenital anomaly of urogenital tract
(12), exposition to diethylstilbestrol in utero (1). Note: several events may have occurred in one case.
cPositive family history: (male) relatives with infertility (12), recurrent miscarriages (4), children with congenital anomalies or mental retardation (2).
.............................................
.............................................................................................................................................................................................
Table III Sperm parameters and patient characteristics in a subgroup of 1144 non-azoospermic men applying for ICSI in
relation to chromosomal abnormalities.
Characteristic n Abnormal karyotype (26) Normal karyotype (1118) Univariate analysis
OR 95% CI P-value
Sperm volume per ml 1144 3.55 (1–13.9) 3.80 (0.1–15.1) 0.953 0.774–1.173 0.649
Sperm concentration per million/ml 1144 5.000 (0.0001–40) 6.000 (0.000003–185) 0.994 0.966–1.023 0.668
Sperm motility per % 1144 26.0 (0–100) 18.0 (0–100) 1.020 1.003–1.018 0.024
TMSC per million 1144 2.95000 (0–38.5) 2.84665 (0–466.2) 0.996 0.975–1.018 0.717
Previous pregnancy by male partner 1135 7.7% 21.4% 0.307 0.072–1.307 0.110
Previous miscarriage(s) 239 50% 34.6% 1.89 0.117–30.6 0.654
ICSI because of TFF 1144 15.4% 16.2% 0.941 0.321–2.76 0.912
FSH per IU/l 464 8.075 (3.33–29.4) 6.830 (0.19–46.6) 1.035 0.969–1.106 0.305
LH per IU/l 209 4.900 (1–10.2) 3.835 (0.09–25.1) 1.098 0.913–1.321 0.320
Increased gonadotrophinsa 465 41.7% 32.2% 1.50 0.469–4.81 0.494
Testosterone per nmol/l 388 17 (6.5–25) 17 (5.8–51) 0.967 0.88–1.1 0.49
Positive andrologic historyb 1114 30.8% 48.9% 0.464 0.200–1.08 0.074
Positive family historyc 1046 20.0% 18.2% 1.12 0.416–3.03 0.820
History of cryptorchidism 1113 15.4% 20.1% 0.721 0.246–2.11 0.551
Data are median (range) or prevalence.
n, Number of cases of which data were available for analysis.
TMSC, total motile sperm count; FSH, follicle-stimulating hormone; LH, luteinizing hormone; TFF, total fertilization failure in previous IVF.
aIncreased gonadotrophins: FSH . 10 IU/l and/or LH . 12 IU/l
bPositive andrologic history: cryptorchidism (223), genital infection (89), vasectomy (30), orchidectomy (44), radiotherapy (8), chemotherapy (16), testicular biopsy (6), hypospadia or
midline defect (6), varicocele (117), spermatocele (5), surgery for hydrocele (6), surgery of urethra or ejaculatory duct (9), surgery for inguinal hernia (116), accidental testicular injury
(28), testicular torsion (22), congenital anomaly of urogenital tract (1), exposition to diethylstilbestrol in utero (3). Note: several events may have occurred in one case.
cPositive family history: (male) relatives with infertility (132), recurrent miscarriages (45), children with congenital anomalies or mental retardation (32).
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the diagnosis of non-obstructive azoospermia is based on elevated
FSH (NICE, 2004; Dohle et al., 2007; Ferlin et al., 2007; Kosar
et al., 2010; NVOG, 2010). No studies have been published in
which the level of gonadotrophins was analyzed in azoospermic and
non-azoospermic men separately for a correlation with chromosomal
abnormalities. In our azoospermia group, men with high gonadotro-
phins had the highest prevalence of chromosomal abnormalities com-
pared with men with normal gonadotrophin levels. FSH was positively
associated with chromosomal abnormalities, although no statistically
signiﬁcant cut-off level could be determined due to the small
number of cases in this subgroup. Future studies should conﬁrm the
association between gonadotrophin levels and chromosomal abnor-
malities in azoospermic men as a simple test to specify the risk of
chromosomal abnormalities. In non-azoospermic men, a univariate re-
gression analysis showed no association between FSH or LH and
chromosomal abnormalities. Our subjects also showed a wide range
of serum total testosterone and we found no association with
chromosomal abnormalities.
Cryptorchidism had a prevalence of 21% in our cohort, and was
almost evenly distributed in men with and without chromosomal ab-
normalities. Cryptorchidism showed no association with chromosomal
abnormalities and our study does not conﬁrm the hypothesis that
cryptorchidism and infertility have a mutual chromosomal cause
(Akre and Richiardi, 2009).
Of the 1223 subjects in our cohort, 20% had previously achieved
conception, of which 71% had achieved at least one pregnancy with
the current partner. These pregnancies were not realized by IVF or
ICSI, but had occurred spontaneously or by intrauterine insemination.
If there had been a previous pregnancy, whether it ended in a miscar-
riage, ectopic pregnancy, stillbirth, a child with congenital anomalies or
a healthy newborn, the chance of ﬁnding a chromosomal abnormality
was signiﬁcantly decreased. This is in agreement with the observation
that chromosomal abnormalities are predominantly found in azoo-
spermic men, while previous pregnancies are mainly seen in the non-
azoospermic group. In 79 azoospermic men, ﬁve reported their part-
ners had had a previous pregnancy. Two of these men had undergone
a vasectomy and one chemotherapy. It is most likely that the pregnan-
cies occurred before the onset of azoospermia. We found no statistic-
ally signiﬁcant association between previous pregnancy or miscarriage
and chromosomal abnormalities in non-azoospermic men.
In the azoospermic men, a positive andrologic history (e.g. crypt-
orchidism, varicocele, genital infection, chemotherapy and vasectomy)
lowered the risk of an aberrant karyotype (OR 0.28). Our data suggest
that azoospermic men who have a plausible explanation for their
azoospermia in their medical history have a lower risk of chromosomal
abnormalities than azoospermic men with an uneventful medical
history. The same was found in non-azoospermic men, although this
association did not reach statistical signiﬁcance.
All couples received an extensive questionnaire on their medical
and family history before their ﬁrst visit to our fertility centre.
However, not all questions were ﬁlled in completely, which resulted
in missing data. Moreover, due to the retrospective design of the
study, we only had a limited number of sperm analyses and
hormone results available. Furthermore, although the cohort consisted
of a large group of infertile men, the prevalence of chromosomal
abnormalities was low. A multivariate regression analysis was per-
formed on all variables and chromosomal abnormalities, but it was
not conclusive due to the small sizes of the different subgroups. We
therefore created a model, based on the univariate regression analysis
and presented it in Fig. 1. This shows that azoospermic men with high
gonadotrophin levels have the highest risk of carrying a chromosomal
abnormality, while a possible explanation for poor sperm quality (i.e. a
positive andrologic history) lowers this risk in azoospermic and
non-azoospermic men. Whether these conclusions apply to all
infertile men remains to be studied.
In conclusion, we show that in our cohort of infertile men, in whom
the a priori risk of chromosomal abnormalities is 3.1% (CI 2.1–4.1),
sperm concentration is not a good predictor for chromosomal abnor-
malities, although the total absence of spermatozoa is. Sperm volume
and motility do not correlate with chromosomal abnormalities. If a
man has previously achieved conception, the risk of a chromosomal
abnormality signiﬁcantly decreases (OR 0.21).
Azoospermic men had a prevalence of chromosomal abnormalities
of 15.2% (CI 7.3–23.1). When gonadotrophin levels are increased
(FSH . 10 IU/l and/or LH . 12 IU/l), the risk of a chromosomal
abnormality increases signiﬁcantly. In azoospermic men with a positive
andrologic history, irrespective of the gonadotrophin levels, the risk
decreases (OR 0.28).
In non-azoospermic men eligible for ICSI, the prevalence of
chromosomal abnormalities was 2.3% (CI 1.4–3.2), and none of the
parameters studied provides a better risk assessment for chromosom-
al abnormalities in this group of men.
The ﬁndings of our study allow for a more speciﬁc risk estimate on
chromosomal abnormalities in subgroups of infertile men. The recom-
mendation on who should be offered karyotyping should be based on
cost-effectiveness studies, in which costs of adverse events due to
chromosomal abnormalities in men (e.g. miscarriages and children
Figure 1 Prevalences (and 95% CIs) of chromosomal abnormalities in
subgroups of men with azoospermia or applying for ICSI. aFSH ≤ 10 IU/l
and LH ≤ 12 IU/l,bFSH. 10 IU/l and/or LH. 12 IU/l.
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with congenital anomalies) should be included. The data obtained in
our cohort can be used in these future economic models.
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